Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinopathy of Prematurity | 13 | 2023 | 66 | 6.740 |
Why?
|
| Laser Coagulation | 7 | 2021 | 54 | 2.520 |
Why?
|
| Angiogenesis Inhibitors | 7 | 2023 | 311 | 2.310 |
Why?
|
| Bevacizumab | 8 | 2023 | 281 | 2.070 |
Why?
|
| Cataract | 2 | 2023 | 86 | 1.260 |
Why?
|
| Infant, Newborn | 13 | 2023 | 2381 | 1.050 |
Why?
|
| Gestational Age | 8 | 2023 | 312 | 0.970 |
Why?
|
| Infant, Premature, Diseases | 2 | 2021 | 78 | 0.940 |
Why?
|
| Aphakia | 1 | 2023 | 10 | 0.900 |
Why?
|
| Intravitreal Injections | 6 | 2023 | 67 | 0.890 |
Why?
|
| Cataract Extraction | 1 | 2023 | 31 | 0.880 |
Why?
|
| Endophthalmitis | 1 | 2023 | 21 | 0.880 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2023 | 39 | 0.870 |
Why?
|
| Lens, Crystalline | 1 | 2023 | 69 | 0.840 |
Why?
|
| Infant, Premature | 5 | 2023 | 291 | 0.760 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2023 | 459 | 0.690 |
Why?
|
| Myopia | 2 | 2017 | 10 | 0.620 |
Why?
|
| Ophthalmology | 1 | 2016 | 39 | 0.530 |
Why?
|
| Retrospective Studies | 9 | 2024 | 8466 | 0.510 |
Why?
|
| Infant | 6 | 2023 | 3051 | 0.480 |
Why?
|
| Tomography, Optical Coherence | 7 | 2024 | 130 | 0.480 |
Why?
|
| Choroid | 2 | 2024 | 33 | 0.440 |
Why?
|
| Communication | 1 | 2016 | 440 | 0.430 |
Why?
|
| Education, Medical, Graduate | 1 | 2016 | 373 | 0.420 |
Why?
|
| Humans | 28 | 2024 | 85796 | 0.410 |
Why?
|
| Proteomics | 1 | 2023 | 212 | 0.400 |
Why?
|
| Physician-Patient Relations | 1 | 2016 | 610 | 0.380 |
Why?
|
| Retinal Detachment | 2 | 2021 | 66 | 0.370 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2023 | 412 | 0.350 |
Why?
|
| Physicians | 1 | 2016 | 672 | 0.320 |
Why?
|
| Child | 6 | 2023 | 6930 | 0.320 |
Why?
|
| Fluorescein Angiography | 4 | 2023 | 96 | 0.310 |
Why?
|
| Scleritis | 1 | 2016 | 5 | 0.290 |
Why?
|
| Sclera | 1 | 2016 | 11 | 0.290 |
Why?
|
| Founder Effect | 1 | 2017 | 104 | 0.290 |
Why?
|
| Internship and Residency | 1 | 2016 | 1011 | 0.290 |
Why?
|
| Streptococcal Infections | 1 | 2016 | 57 | 0.280 |
Why?
|
| Retinal Vessels | 2 | 2023 | 58 | 0.260 |
Why?
|
| Retinal Perforations | 1 | 2024 | 19 | 0.240 |
Why?
|
| Diabetic Retinopathy | 1 | 2024 | 85 | 0.220 |
Why?
|
| Parturition | 1 | 2022 | 21 | 0.220 |
Why?
|
| Smartphone | 1 | 2023 | 36 | 0.220 |
Why?
|
| Child, Preschool | 2 | 2020 | 3612 | 0.220 |
Why?
|
| Insurance, Health | 1 | 2023 | 156 | 0.220 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2021 | 8 | 0.210 |
Why?
|
| Fovea Centralis | 1 | 2021 | 21 | 0.210 |
Why?
|
| Mucolipidoses | 1 | 2021 | 3 | 0.200 |
Why?
|
| Connective Tissue Diseases | 1 | 2021 | 67 | 0.190 |
Why?
|
| Movement | 1 | 2022 | 299 | 0.180 |
Why?
|
| Vision, Low | 1 | 2019 | 15 | 0.170 |
Why?
|
| Administration, Ophthalmic | 1 | 2019 | 9 | 0.170 |
Why?
|
| Refraction, Ocular | 1 | 2019 | 9 | 0.170 |
Why?
|
| Vitreous Hemorrhage | 1 | 2018 | 11 | 0.170 |
Why?
|
| Hearing Loss | 1 | 2019 | 56 | 0.170 |
Why?
|
| Cerebral Palsy | 1 | 2019 | 90 | 0.160 |
Why?
|
| Vitreous Body | 1 | 2018 | 54 | 0.160 |
Why?
|
| Incidence | 1 | 2023 | 1543 | 0.160 |
Why?
|
| Cross-Sectional Studies | 4 | 2023 | 1604 | 0.160 |
Why?
|
| Keratoconus | 1 | 2017 | 9 | 0.160 |
Why?
|
| Hypertension | 1 | 2023 | 703 | 0.150 |
Why?
|
| Cornea | 1 | 2017 | 69 | 0.150 |
Why?
|
| Odds Ratio | 1 | 2019 | 676 | 0.150 |
Why?
|
| Risk Factors | 2 | 2023 | 5251 | 0.140 |
Why?
|
| Female | 9 | 2024 | 44218 | 0.140 |
Why?
|
| Male | 8 | 2024 | 40654 | 0.130 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 728 | 0.120 |
Why?
|
| Aqueous Humor | 1 | 2023 | 23 | 0.110 |
Why?
|
| Syndrome | 2 | 2021 | 445 | 0.110 |
Why?
|
| Mass Spectrometry | 1 | 2023 | 189 | 0.110 |
Why?
|
| Postoperative Complications | 1 | 2023 | 2204 | 0.110 |
Why?
|
| Fundus Oculi | 2 | 2023 | 33 | 0.100 |
Why?
|
| Clinical Competence | 1 | 2016 | 756 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2023 | 447 | 0.090 |
Why?
|
| Time Factors | 1 | 2019 | 5178 | 0.090 |
Why?
|
| Adult | 5 | 2023 | 25522 | 0.090 |
Why?
|
| Prospective Studies | 3 | 2022 | 4160 | 0.080 |
Why?
|
| Fluoresceins | 1 | 2018 | 43 | 0.080 |
Why?
|
| Axial Length, Eye | 1 | 2017 | 1 | 0.080 |
Why?
|
| Retinoscopy | 1 | 2017 | 2 | 0.080 |
Why?
|
| Zinc | 1 | 2008 | 92 | 0.080 |
Why?
|
| South Dakota | 1 | 2017 | 47 | 0.080 |
Why?
|
| Visual Acuity | 2 | 2018 | 194 | 0.070 |
Why?
|
| Biometry | 1 | 2017 | 66 | 0.070 |
Why?
|
| Anterior Eye Segment | 1 | 2016 | 6 | 0.070 |
Why?
|
| Organometallic Compounds | 1 | 2008 | 132 | 0.070 |
Why?
|
| Biomarkers | 1 | 2023 | 1697 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 242 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 425 | 0.070 |
Why?
|
| Staphylococcus aureus | 1 | 2008 | 269 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2008 | 666 | 0.060 |
Why?
|
| Ultrasonography | 1 | 2016 | 692 | 0.060 |
Why?
|
| Vitrectomy | 1 | 2024 | 52 | 0.060 |
Why?
|
| Morbidity | 1 | 2023 | 141 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 746 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 1561 | 0.050 |
Why?
|
| Adolescent | 2 | 2021 | 8959 | 0.050 |
Why?
|
| Retina | 1 | 2024 | 213 | 0.050 |
Why?
|
| Arthritis | 1 | 2021 | 46 | 0.050 |
Why?
|
| Video Recording | 1 | 2022 | 190 | 0.050 |
Why?
|
| Lasers | 1 | 2021 | 106 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 3591 | 0.050 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2021 | 46 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2021 | 196 | 0.050 |
Why?
|
| Capillaries | 1 | 2021 | 90 | 0.050 |
Why?
|
| Neuraminidase | 1 | 2021 | 45 | 0.050 |
Why?
|
| Healthy Volunteers | 1 | 2021 | 143 | 0.050 |
Why?
|
| Young Adult | 2 | 2021 | 5961 | 0.040 |
Why?
|
| Corneal Topography | 1 | 2017 | 8 | 0.040 |
Why?
|
| Aged | 2 | 2021 | 18161 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 6479 | 0.040 |
Why?
|
| Algorithms | 1 | 2024 | 1824 | 0.030 |
Why?
|
| Middle Aged | 2 | 2021 | 24742 | 0.030 |
Why?
|
| Pregnancy | 1 | 2022 | 2899 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2024 | 7831 | 0.020 |
Why?
|
| Oxacillin | 1 | 2008 | 1 | 0.020 |
Why?
|
| Cations, Divalent | 1 | 2008 | 39 | 0.020 |
Why?
|
| Solutions | 1 | 2008 | 85 | 0.020 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2008 | 71 | 0.020 |
Why?
|
| Phospholipids | 1 | 2008 | 111 | 0.020 |
Why?
|
| Vancomycin | 1 | 2008 | 72 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2008 | 165 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2008 | 373 | 0.020 |
Why?
|
| Water | 1 | 2008 | 277 | 0.020 |
Why?
|